Logo image of UGE.CA

UGE INTERNATIONAL LTD (UGE.CA) Stock Fundamental Analysis

TSX-V:UGE - TSX Venture Exchange - CA9035104020 - Common Stock - Currency: CAD

2  +0.01 (+0.5%)

Fundamental Rating

1

UGE gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 7 industry peers in the Construction & Engineering industry. UGE has a bad profitability rating. Also its financial health evaluation is rather negative. UGE is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

UGE had negative earnings in the past year.
In the past year UGE has reported a negative cash flow from operations.
UGE had negative earnings in each of the past 5 years.
UGE had a negative operating cash flow in each of the past 5 years.
UGE.CA Yearly Net Income VS EBIT VS OCF VS FCFUGE.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 -10M -20M -30M

1.2 Ratios

The Return On Assets of UGE (-19.79%) is worse than 75.00% of its industry peers.
Industry RankSector Rank
ROA -19.79%
ROE N/A
ROIC N/A
ROA(3y)-19.44%
ROA(5y)-29.86%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
UGE.CA Yearly ROA, ROE, ROICUGE.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200 400 600

1.3 Margins

UGE's Gross Margin of 56.24% is amongst the best of the industry. UGE outperforms 87.50% of its industry peers.
UGE's Gross Margin has improved in the last couple of years.
UGE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 56.24%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y15.94%
GM growth 5Y42.45%
UGE.CA Yearly Profit, Operating, Gross MarginsUGE.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -200 -400 -600 -800 -1K

More info and screens

0

2. Health

2.1 Basic Checks

UGE does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, UGE has more shares outstanding
Compared to 5 years ago, UGE has more shares outstanding
The debt/assets ratio for UGE is higher compared to a year ago.
UGE.CA Yearly Shares OutstandingUGE.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M
UGE.CA Yearly Total Debt VS Total AssetsUGE.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M

2.2 Solvency

UGE has an Altman-Z score of -1.55. This is a bad value and indicates that UGE is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of UGE (-1.55) is worse than 75.00% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -1.55
ROIC/WACCN/A
WACC6.37%
UGE.CA Yearly LT Debt VS Equity VS FCFUGE.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M 60M

2.3 Liquidity

A Current Ratio of 0.25 indicates that UGE may have some problems paying its short term obligations.
UGE has a Current ratio of 0.25. This is in the lower half of the industry: UGE underperforms 75.00% of its industry peers.
A Quick Ratio of 0.25 indicates that UGE may have some problems paying its short term obligations.
UGE has a Quick ratio of 0.25. This is in the lower half of the industry: UGE underperforms 75.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.25
Quick Ratio 0.25
UGE.CA Yearly Current Assets VS Current LiabilitesUGE.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M

More info and screens

4

3. Growth

3.1 Past

UGE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -70.37%.
The Revenue for UGE has decreased by -71.01% in the past year. This is quite bad
UGE shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -41.18% yearly.
EPS 1Y (TTM)-70.37%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-33.33%
Revenue 1Y (TTM)-71.01%
Revenue growth 3Y-5.62%
Revenue growth 5Y-41.18%
Sales Q2Q%-10.3%

3.2 Future

UGE is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 31.23% yearly.
Based on estimates for the next years, UGE will show a very strong growth in Revenue. The Revenue will grow by 157.73% on average per year.
EPS Next Y-12.58%
EPS Next 2Y-2.08%
EPS Next 3Y20.75%
EPS Next 5Y31.23%
Revenue Next Year64.19%
Revenue Next 2Y138.13%
Revenue Next 3Y150.23%
Revenue Next 5Y157.73%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
UGE.CA Yearly Revenue VS EstimatesUGE.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 100M 200M 300M
UGE.CA Yearly EPS VS EstimatesUGE.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 0.5 1 1.5 2

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

UGE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for UGE. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
UGE.CA Price Earnings VS Forward Price EarningsUGE.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
UGE.CA Per share dataUGE.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4 -0.6 -0.8 -1

4.3 Compensation for Growth

A more expensive valuation may be justified as UGE's earnings are expected to grow with 20.75% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-2.08%
EPS Next 3Y20.75%

More info and screens

0

5. Dividend

5.1 Amount

UGE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

UGE INTERNATIONAL LTD

TSX-V:UGE (8/15/2024, 7:00:00 PM)

2

+0.01 (+0.5%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)08-14 2024-08-14
Earnings (Next)11-27 2024-11-27
Inst Owners0.17%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap0
Analysts42.22
Price Target2.04 (2%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-22.47%
Min EPS beat(2)-37.06%
Max EPS beat(2)-7.87%
EPS beat(4)0
Avg EPS beat(4)-100.76%
Min EPS beat(4)-323.65%
Max EPS beat(4)-7.87%
EPS beat(8)2
Avg EPS beat(8)-58.63%
EPS beat(12)2
Avg EPS beat(12)-63.24%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-49.43%
Min Revenue beat(2)-54.21%
Max Revenue beat(2)-44.66%
Revenue beat(4)0
Avg Revenue beat(4)-45.95%
Min Revenue beat(4)-55.89%
Max Revenue beat(4)-29.06%
Revenue beat(8)1
Avg Revenue beat(8)-16.05%
Revenue beat(12)2
Avg Revenue beat(12)-7.17%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)9.09%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0.7%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-43.83%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 41.59
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.63
EYN/A
EPS(NY)-0.61
Fwd EYN/A
FCF(TTM)-1.32
FCFYN/A
OCF(TTM)-0.71
OCFYN/A
SpS0.05
BVpS-0.8
TBVpS-0.84
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -19.79%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 56.24%
FCFM N/A
ROA(3y)-19.44%
ROA(5y)-29.86%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y15.94%
GM growth 5Y42.45%
F-Score1
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 4483.66%
Cap/Sales 1268.91%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.25
Quick Ratio 0.25
Altman-Z -1.55
F-Score1
WACC6.37%
ROIC/WACCN/A
Cap/Depr(3y)3619.14%
Cap/Depr(5y)2980.59%
Cap/Sales(3y)484.64%
Cap/Sales(5y)316.8%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-70.37%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-33.33%
EPS Next Y-12.58%
EPS Next 2Y-2.08%
EPS Next 3Y20.75%
EPS Next 5Y31.23%
Revenue 1Y (TTM)-71.01%
Revenue growth 3Y-5.62%
Revenue growth 5Y-41.18%
Sales Q2Q%-10.3%
Revenue Next Year64.19%
Revenue Next 2Y138.13%
Revenue Next 3Y150.23%
Revenue Next 5Y157.73%
EBIT growth 1Y-93.7%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year19.64%
EBIT Next 3Y40.19%
EBIT Next 5Y65.4%
FCF growth 1Y-205.71%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-174.11%
OCF growth 3YN/A
OCF growth 5YN/A